Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5'-Nucleotidase is an enzyme that catalyzes the hydrolysis of phosphate groups from nucleoside monophosphates at the 5' position, producing corresponding nucleosides and inorganic phosphate[2][4]. It exists both as a soluble cytoplasmic enzyme involved in nucleotide metabolism and as a membrane-bound ectoenzyme—most notably known as CD73—which plays a key role in generating extracellular adenosine from AMP[2][6]. This activity regulates purinergic signaling with broad implications for immune modulation, vascular function, inflammation control, and cancer biology[1][2][6]. The enzyme has wide substrate specificity but primarily acts on AMP; its activity can influence resistance mechanisms against certain chemotherapeutic agents by dephosphoryting active drug metabolites[5].
Drugs targeting this enzyme typically act as inhibitors to block the conversion of AMP to adenosine, thereby reducing immunosuppressive signaling mediated by adenosine in the tumor microenvironment or inflamed tissues.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5'-Nucleotidase (5'-NT).